Cerebrospinal fluid chitinases as biomarkers for Amyotrophic Lateral Sclerosis
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10451/49468 |
Resumo: | © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
id |
RCAP_93fba6f862fd70f5083297b35af96511 |
---|---|
oai_identifier_str |
oai:repositorio.ul.pt:10451/49468 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Cerebrospinal fluid chitinases as biomarkers for Amyotrophic Lateral SclerosisAmyotrophic lateral sclerosisBiomarkersCerebrospinal fluidChitinases© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).Amyotrophic lateral sclerosis (ALS) is a neurodegenerative neuromuscular disease that affects motor neurons controlling voluntary muscles. Survival is usually 2-5 years after onset, and death occurs due to respiratory failure. The identification of biomarkers would be very useful to help in disease diagnosis and for patient stratification based on, e.g., progression rate, with implications in therapeutic trials. Neurofilaments constitute already-promising markers for ALS and, recently, chitinases have emerged as novel marker targets for the disease. Here, we investigated cerebrospinal fluid (CSF) chitinases as potential markers for ALS. Chitotriosidase (CHIT1), chitinase-3-like protein 1 (CHI3L1), chitinase-3-like protein 2 (CHI3L2) and the benchmark marker phosphoneurofilament heavy chain (pNFH) were quantified by an enzyme-linked immunosorbent assay (ELISA) from the CSF of 34 ALS patients and 24 control patients with other neurological diseases. CSF was also analyzed by UHPLC-mass spectrometry. All three chitinases, as well as pNFH, were found to correlate with disease progression rate. Furthermore, CHIT1 was elevated in ALS patients with high diagnostic performance, as was pNFH. On the other hand, CHIT1 correlated with forced vital capacity (FVC). The three chitinases correlated with pNFH, indicating a relation between degeneration and neuroinflammation. In conclusion, our results supported the value of CHIT1 as a diagnostic and progression rate biomarker, and its potential as respiratory function marker. The results opened novel perspectives to explore chitinases as biomarkers and their functional relevance in ALS.We acknowledge iNOVA4Health – UIDB/04462/2020 and UIDP/04462/2020, a program financially supported by Fundação para a Ciência e Tecnologia/Ministério da Ciência, Tecnologia e Ensino Superior, through national funds.MDPIRepositório da Universidade de LisboaCosta, JuliaGromicho, MartaPronto Laborinho, Ana CatarinaAlmeida, ConceiçãoGomes, Ricardo A.Guerreiro, Ana C. L.Oliva, AbelPinto, SusanaCarvalho, Mamede2021-09-08T14:27:57Z20212021-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10451/49468engDiagnostics (Basel). 2021 Jul 5;11(7):121010.3390/diagnostics110712102075-4418info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-08T16:53:16Zoai:repositorio.ul.pt:10451/49468Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T22:01:06.286605Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Cerebrospinal fluid chitinases as biomarkers for Amyotrophic Lateral Sclerosis |
title |
Cerebrospinal fluid chitinases as biomarkers for Amyotrophic Lateral Sclerosis |
spellingShingle |
Cerebrospinal fluid chitinases as biomarkers for Amyotrophic Lateral Sclerosis Costa, Julia Amyotrophic lateral sclerosis Biomarkers Cerebrospinal fluid Chitinases |
title_short |
Cerebrospinal fluid chitinases as biomarkers for Amyotrophic Lateral Sclerosis |
title_full |
Cerebrospinal fluid chitinases as biomarkers for Amyotrophic Lateral Sclerosis |
title_fullStr |
Cerebrospinal fluid chitinases as biomarkers for Amyotrophic Lateral Sclerosis |
title_full_unstemmed |
Cerebrospinal fluid chitinases as biomarkers for Amyotrophic Lateral Sclerosis |
title_sort |
Cerebrospinal fluid chitinases as biomarkers for Amyotrophic Lateral Sclerosis |
author |
Costa, Julia |
author_facet |
Costa, Julia Gromicho, Marta Pronto Laborinho, Ana Catarina Almeida, Conceição Gomes, Ricardo A. Guerreiro, Ana C. L. Oliva, Abel Pinto, Susana Carvalho, Mamede |
author_role |
author |
author2 |
Gromicho, Marta Pronto Laborinho, Ana Catarina Almeida, Conceição Gomes, Ricardo A. Guerreiro, Ana C. L. Oliva, Abel Pinto, Susana Carvalho, Mamede |
author2_role |
author author author author author author author author |
dc.contributor.none.fl_str_mv |
Repositório da Universidade de Lisboa |
dc.contributor.author.fl_str_mv |
Costa, Julia Gromicho, Marta Pronto Laborinho, Ana Catarina Almeida, Conceição Gomes, Ricardo A. Guerreiro, Ana C. L. Oliva, Abel Pinto, Susana Carvalho, Mamede |
dc.subject.por.fl_str_mv |
Amyotrophic lateral sclerosis Biomarkers Cerebrospinal fluid Chitinases |
topic |
Amyotrophic lateral sclerosis Biomarkers Cerebrospinal fluid Chitinases |
description |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-09-08T14:27:57Z 2021 2021-01-01T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10451/49468 |
url |
http://hdl.handle.net/10451/49468 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Diagnostics (Basel). 2021 Jul 5;11(7):1210 10.3390/diagnostics11071210 2075-4418 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
MDPI |
publisher.none.fl_str_mv |
MDPI |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799134558890754048 |